We are live on ! Find out more
ANAB icon

AnaptysBio
ANAB

116 hedge funds and large institutions have $545M invested in AnaptysBio in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 34 increasing their positions, 38 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.08% more ownership

Funds ownership: 114.12% → 114.2% (+0.08%)

0% more funds holding

Funds holding: 116 → 116 (0)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

0% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 14

6% less call options, than puts

Call options by funds: $1.01M | Put options by funds: $1.07M

11% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 38

11% less capital invested

Capital invested by funds: $615M → $545M (-$70.4M)

Holders
116
Holders Change
–
Holders Change %
0%
% of All Funds
1.84%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
14
Increased
34
Reduced
38
Closed
14
Calls
$1.01M
Puts
$1.07M
Net Calls
-$63K
Net Calls Change
-$92K

Top Buyers

Rank Fund Capital Flow
1
DTC
Deep Track Capital
Connecticut
+$25.7M
2
SVCM
Saturn V Capital Management
Texas
+$11M
3
SCM
Suvretta Capital Management
New York
+$9.15M
4
FLAM
First Light Asset Management
Minnesota
+$8.94M
5
EAM
Eventide Asset Management
Massachusetts
+$8.15M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$12.8M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
-$12.8M
3
DM
Deerfield Management
New York
-$12.5M
4
RSCM
Rock Springs Capital Management
Maryland
-$6.95M
5
State Street
State Street
Massachusetts
-$5.33M
Name Holding Trade Value Shares
Change 		Change in
Stake
Assenagon Asset Management
26
Assenagon Asset Management
Luxembourg
$3.98M -$5.21M -273,216 -55%
Jacobs Levy Equity Management
27
Jacobs Levy Equity Management
New Jersey
$3.71M +$154K +8,064 +4%
Northern Trust
28
Northern Trust
Illinois
$3.6M -$45.6K -2,390 -1%
Citadel Advisors
29
Citadel Advisors
Florida
$3.35M +$617K +32,339 +21%
Goldman Sachs
30
Goldman Sachs
New York
$3.2M +$885K +46,365 +35%
D.E. Shaw & Co
31
D.E. Shaw & Co
New York
$2.62M -$1.14M -59,904 -29%
Charles Schwab
32
Charles Schwab
California
$2.57M +$64.9K +3,399 +2%
UOC
33
UBS O'Connor
Illinois
$2.24M – – –
Two Sigma Advisers
34
Two Sigma Advisers
New York
$2.1M -$170K -8,900 -7%
Two Sigma Investments
35
Two Sigma Investments
New York
$1.93M -$735K -38,520 -26%
BBA
36
Baker Bros. Advisors
New York
$1.91M -$12.8M -669,727 -86%
Hudson Bay Capital Management
37
Hudson Bay Capital Management
Connecticut
$1.8M +$954K +50,000 +100%
Macquarie Group
38
Macquarie Group
Australia
$1.68M – – –
Renaissance Technologies
39
Renaissance Technologies
New York
$1.67M +$662K +34,700 +60%
Morgan Stanley
40
Morgan Stanley
New York
$1.45M +$179K +9,369 +13%
N
41
Nuveen
North Carolina
$1.3M +$3.03K +159 +0.2%
Fisher Asset Management
42
Fisher Asset Management
Washington
$1.27M – – –
Bank of New York Mellon
43
Bank of New York Mellon
New York
$1.25M +$458 +24 +0%
Rafferty Asset Management
44
Rafferty Asset Management
New York
$1.12M -$578K -30,314 -33%
Bank of America
45
Bank of America
North Carolina
$1.09M -$1.14M -59,516 -49%
Squarepoint
46
Squarepoint
New York
$942K +$400K +20,968 +67%
Ameriprise
47
Ameriprise
Minnesota
$807K -$820K -42,947 -49%
Victory Capital Management
48
Victory Capital Management
Texas
$785K +$834K +43,690 New
Ensign Peak Advisors
49
Ensign Peak Advisors
Utah
$780K – – –
ECM
50
ExodusPoint Capital Management
New York
$728K -$917K -48,046 -54%
1
2
3 4 5

ANAB Hedge Fund Activity: Q3 2023 in Review

116 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in AnaptysBio (ANAB) for Q3 2023, worth a combined $545M — down 11% from $615M a quarter earlier.

Fund positioning in ANAB was balanced in Q3 2023: 14 funds opened new positions, 14 closed out, 34 added to existing stakes and 38 trimmed.

The largest buyer was Deep Track Capital, opening a new position worth an estimated $25.7M. The largest seller was Baker Bros. Advisors, cutting an estimated $12.8M.

  • 116 institutional investors held AnaptysBio (ANAB) as of Q3 2023, unchanged from Q2 2023.
  • Funds reported $545M of AnaptysBio stock for Q3 2023, down 11% quarter-over-quarter.
  • 14 funds opened new AnaptysBio positions in Q3 2023 and 14 closed out, a net change of 0 holders.
  • The largest AnaptysBio buyer in Q3 2023 was Deep Track Capital, an estimated $25.7M added.
  • The largest AnaptysBio seller in Q3 2023 was Baker Bros. Advisors, an estimated $12.8M sold.

Based on aggregated 13F filings for Q3 2023.